Epinephrine Injection
Pricing Report NDC 76329-3318-1

Current NADAC: $1.27686 per ML · Effective Oct 21, 2026 · Est. package price $127.69 (100 ML)

Current Package Pricing Information

The current wholesale acquisition cost for Epinephrine (NDC 76329-3318-1) is $1.27686 per ML. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Oct 21, 2026.

As a a human prescription drug provided by International Medication Systems, Limited, this medication is distributed in a 10 CARTON in 1 PACKAGE / 1 SYRINGE in 1 CARTON / 10 mL in 1 SYRINGE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$1.27686
Per ML

Effective Date
Oct 21, 2026
Billable Units
100 ML
Estimated Package Price
$127.69
Data Status
As of Nov 04, 2026
C/I - Chain or Independent Pharmacy
Package NDC
Description
10 CARTON in 1 PACKAGE / 1 SYRINGE in 1 CARTON / 10 mL in 1 SYRINGE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The NADAC was calculated based on package size.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since May 2024, the NADAC wholesale price for (NDC ) has moved within a range of $1.09410 to $1.27686 per ML. Over this 2 years and 4 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$1.0941 - $1.2769
Market Volatility
16.70% Variance
Latest Trend
3.14%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Oct 21, 2026 $1.27686 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Sep 23, 2026 $1.23804 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Aug 19, 2026 $1.22626 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jul 22, 2026 $1.21279 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jun 17, 2026 $1.20423 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
May 20, 2026 $1.19395 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Apr 22, 2026 $1.19100 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Mar 18, 2026 $1.20238 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Feb 18, 2026 $1.19476 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jan 21, 2026 $1.19359 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Dec 17, 2025 $1.20480 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Nov 19, 2025 $1.21097 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 5: The NADAC was calculated based on package size.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: November 04, 2026